Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Statins and neuroprotection.

N Delanty¹, C J Vaughan, N Sheehy

¹Department of Neurology and Clinical Neurological Sciences, Beaumont Hospital and Royal College of Surgeons in Ireland, Dublin 9, Ireland.

Expert Opinion on Investigational Drugs

|January 5, 2002

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Neurology Undergraduate Medical Education: A Scoping Review.

European journal of neurology·2025

Same author

Measurement of lumbar vertebral body attenuation at PET-CT is a reliable method of diagnosing osteoporosis.

Clinical radiology·2025

Same author

Perineural tumour spread in head and neck cancer: a pictorial review.

Clinical radiology·2024

Same author

Pericardial Fat Necrosis.

Irish medical journal·2023

Same author

A Review of a Tertiary Referral Centre's CT Coronary Angiography Programme.

Irish medical journal·2022

Same author

Tuberous Sclerosis: A Rare Disease with an Orphan Complex.

Irish medical journal·2022

Same journal

Investigational new drug TAP-1502 beginning clinical study for seborrheic dermatitis.

Expert opinion on investigational drugs·2026

Same journal

Cannabinoid use in adults with sickle cell disease: therapeutic development and clinical insights.

Expert opinion on investigational drugs·2026

Same journal

Odronextamab: a bispecific antibody for follicular lymphoma.

Expert opinion on investigational drugs·2026

Same journal

Evaluating the investigational drug landscape for <i>ESR1</i>-mutated, estrogen receptor-positive, HER2-negative metastatic breast cancer.

Expert opinion on investigational drugs·2026

Same journal

Darigabat and subtype-selective GABA-A modulation: pharmacology, clinical development, and translational challenges.

Expert opinion on investigational drugs·2026

Same journal

Safety, tolerability, and pharmacokinetics of HL-300, a novel topical pan-JAK inhibitor, in healthy Chinese adults: a first-in-human, randomized, double-blind, placebo-controlled phase I trial.

Expert opinion on investigational drugs·2026

See all related articles

Statins, known for heart health, show promise in reducing stroke risk and protecting the brain. Emerging evidence suggests these cholesterol-lowering drugs may also prevent dementia onset.

Area of Science:

Cardiovascular Medicine
Neurology
Pharmacology

Background:

Beta-hydroxy-beta-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) are established for preventing coronary artery disease.
Statins are widely used for primary prevention in hypercholesterolemia and secondary prevention in established coronary vascular disease.

Purpose of the Study:

To review the neuroprotective potential of statins, particularly during stroke.
To examine observational data on statins' role in dementia prevention.

Main Methods:

Review of existing scientific literature and clinical evidence.
Analysis of observational studies investigating statin use and neurological outcomes.

Main Results:

Related Experiment Videos

Statins demonstrate beneficial effects beyond lipid-lowering, including potential stroke risk reduction.

Evidence suggests statins may offer neuroprotection within the brain parenchyma during ischemic events.

Conclusions:

Statins exhibit promising neuroprotective properties relevant to stroke.
Observational data support a potential role for statins in preventing dementia.